James T. Willerson

1 ta ish

St. Luke's Episcopal Hospital

1. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

   Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca +11

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.072357